# Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C

> **NCT02383940** · PHASE2 · COMPLETED · sponsor: **Lexicon Pharmaceuticals** · enrollment: 87 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Sotagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02383940
- **Lead sponsor:** Lexicon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2020-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02383940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02383940, "Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02383940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*